-+ 0.00%
-+ 0.00%
-+ 0.00%
Regeneron Pharma Now Expects Q1 GAAP And Non-GAAP Results To Include Acquired IPR&D Charge Of ~$102M On Pre-Tax Basis
Share
Listen to the news

-SEC Filing

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending